Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04063397 · ClinicalTrials.gov registry record
Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia
A clinical trial of Preeclampsia Severe or Mild and Cardiac Complication, sponsored by Ohio State University.
- Completed
- Registry status
- 27
- Enrollment target
- 1
- Study location
NCT04063397 is a study of Preeclampsia Severe or Mild and Cardiac Complication that has completed, run by Ohio State University. The registered enrollment target is 27 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04063397, a study of Preeclampsia Severe or Mild and Cardiac Complication, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators plan to enroll women with PE prospectively to evaluate incremental cardiovascular risk in those who have PE with severe features. This study includes detailed echocardiographic evaluation at several time points. With the current proposal, the investigators aim to collect blood to evaluate several biomarkers to determine if there is a correlation with short and medium-term cardiovascular risk. This opens the door to earlier detection, treatment and improved cardiovascular outcomes.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Blood draw
- DIAGNOSTIC_TEST Echocardiogram
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2019-08-19 |
| Est. Completion | 2023-12-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04063397
The ClinicalTrials.gov registry entry for NCT04063397 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Preeclampsia Severe or Mild appearing as the primary indexed condition, and to 2 interventions - of which Blood draw is the first listed.
NCT04063397 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04063397 about?
NCT04063397 is a clinical study titled "Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia". The investigators plan to enroll women with PE prospectively to evaluate incremental cardiovascular risk in those who have PE with severe features. This study includes detailed echocardiographic evaluation at several time points. With the current proposal, the investigators aim to collect blood to e...
What is the current status of trial NCT04063397?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2019-08-19. Estimated completion is 2023-12-14.
What conditions does trial NCT04063397 study?
This clinical trial studies the following conditions: Preeclampsia Severe or Mild, Cardiac Complication.
What interventions are being tested in trial NCT04063397?
The interventions under investigation include: Blood draw (DIAGNOSTIC_TEST), Echocardiogram (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04063397?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04063397 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.